While nSMase2 inhibition has been reported to decrease tau propagation in vivo in a mouse model [20], the effects of nSMase2 inhibition on α-Syn propagation in brain in a PD model have not previously been reported. This evidence concerns the gene MAPT and Parkinson disease.